Cargando…

The Clinical Value of Lipid Abnormalities in Early Stage Cervical Cancer

BACKGROUND: To describe the characteristics of plasma lipid proliferation in cervical cancer and further evaluate the prognostic significance of lipid levels in cervical cancer. METHODS: We retrospectively reviewed 1713 patients with cervical cancer in our hospital. The preoperative plasma lipid pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Qi, Wang, Luhui, Jin, Mengya, Shou, Yueyao, Zhu, Haiyan, Li, Anyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012499/
https://www.ncbi.nlm.nih.gov/pubmed/35431573
http://dx.doi.org/10.2147/IJGM.S352934
_version_ 1784687807585845248
author Jiang, Qi
Wang, Luhui
Jin, Mengya
Shou, Yueyao
Zhu, Haiyan
Li, Anyang
author_facet Jiang, Qi
Wang, Luhui
Jin, Mengya
Shou, Yueyao
Zhu, Haiyan
Li, Anyang
author_sort Jiang, Qi
collection PubMed
description BACKGROUND: To describe the characteristics of plasma lipid proliferation in cervical cancer and further evaluate the prognostic significance of lipid levels in cervical cancer. METHODS: We retrospectively reviewed 1713 patients with cervical cancer in our hospital. The preoperative plasma lipid profile, including cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL), and low-density lipoprotein cholesterol (LDL), of 1713 cervical cancer patients was compared with that of 10,397 healthy women. Then, we evaluated the impact of lipids on overall survival (OS) and recurrence-free survival (RFS) in cervical cancer using univariate and multivariate Cox models. RESULTS: While plasma TC, TG, and LDL were significantly higher, HDL was lower in patients with cervical cancer than in healthy women. TG was identified as an independent predictor for RFS and OS among patients with cervical cancer. Further stratified by age, patients with higher TGs showed a significantly worse RFS and OS than those with lower TGs among patients ≥50 years old but not among those <50 years old. CONCLUSION: Cervical cancer was associated with a disordered lipid profile. Hypertriglyceridemia was an independent poor prognostic indicator for cervical cancer, especially for elderly patients. Strengthening lipid management may be beneficial for improving postoperative OS and RFS in patients with cervical cancer.
format Online
Article
Text
id pubmed-9012499
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-90124992022-04-16 The Clinical Value of Lipid Abnormalities in Early Stage Cervical Cancer Jiang, Qi Wang, Luhui Jin, Mengya Shou, Yueyao Zhu, Haiyan Li, Anyang Int J Gen Med Original Research BACKGROUND: To describe the characteristics of plasma lipid proliferation in cervical cancer and further evaluate the prognostic significance of lipid levels in cervical cancer. METHODS: We retrospectively reviewed 1713 patients with cervical cancer in our hospital. The preoperative plasma lipid profile, including cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL), and low-density lipoprotein cholesterol (LDL), of 1713 cervical cancer patients was compared with that of 10,397 healthy women. Then, we evaluated the impact of lipids on overall survival (OS) and recurrence-free survival (RFS) in cervical cancer using univariate and multivariate Cox models. RESULTS: While plasma TC, TG, and LDL were significantly higher, HDL was lower in patients with cervical cancer than in healthy women. TG was identified as an independent predictor for RFS and OS among patients with cervical cancer. Further stratified by age, patients with higher TGs showed a significantly worse RFS and OS than those with lower TGs among patients ≥50 years old but not among those <50 years old. CONCLUSION: Cervical cancer was associated with a disordered lipid profile. Hypertriglyceridemia was an independent poor prognostic indicator for cervical cancer, especially for elderly patients. Strengthening lipid management may be beneficial for improving postoperative OS and RFS in patients with cervical cancer. Dove 2022-04-11 /pmc/articles/PMC9012499/ /pubmed/35431573 http://dx.doi.org/10.2147/IJGM.S352934 Text en © 2022 Jiang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Jiang, Qi
Wang, Luhui
Jin, Mengya
Shou, Yueyao
Zhu, Haiyan
Li, Anyang
The Clinical Value of Lipid Abnormalities in Early Stage Cervical Cancer
title The Clinical Value of Lipid Abnormalities in Early Stage Cervical Cancer
title_full The Clinical Value of Lipid Abnormalities in Early Stage Cervical Cancer
title_fullStr The Clinical Value of Lipid Abnormalities in Early Stage Cervical Cancer
title_full_unstemmed The Clinical Value of Lipid Abnormalities in Early Stage Cervical Cancer
title_short The Clinical Value of Lipid Abnormalities in Early Stage Cervical Cancer
title_sort clinical value of lipid abnormalities in early stage cervical cancer
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012499/
https://www.ncbi.nlm.nih.gov/pubmed/35431573
http://dx.doi.org/10.2147/IJGM.S352934
work_keys_str_mv AT jiangqi theclinicalvalueoflipidabnormalitiesinearlystagecervicalcancer
AT wangluhui theclinicalvalueoflipidabnormalitiesinearlystagecervicalcancer
AT jinmengya theclinicalvalueoflipidabnormalitiesinearlystagecervicalcancer
AT shouyueyao theclinicalvalueoflipidabnormalitiesinearlystagecervicalcancer
AT zhuhaiyan theclinicalvalueoflipidabnormalitiesinearlystagecervicalcancer
AT lianyang theclinicalvalueoflipidabnormalitiesinearlystagecervicalcancer
AT jiangqi clinicalvalueoflipidabnormalitiesinearlystagecervicalcancer
AT wangluhui clinicalvalueoflipidabnormalitiesinearlystagecervicalcancer
AT jinmengya clinicalvalueoflipidabnormalitiesinearlystagecervicalcancer
AT shouyueyao clinicalvalueoflipidabnormalitiesinearlystagecervicalcancer
AT zhuhaiyan clinicalvalueoflipidabnormalitiesinearlystagecervicalcancer
AT lianyang clinicalvalueoflipidabnormalitiesinearlystagecervicalcancer